Related references
Note: Only part of the references are listed.New 1,3,4-oxadiazoles linked with the 1,2,3-triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud et al.
ARCHIV DER PHARMAZIE (2022)
Discovery of new pyrimido[5,4-c]quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies
Ramadan A. Mekheimer et al.
BIOORGANIC CHEMISTRY (2022)
Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a] indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Hesham A. M. Gomaa et al.
BIOORGANIC CHEMISTRY (2022)
Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers
Heba S. A. Elzahabi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1,4]diazepine derivatives as potent EGFR/CDK2 inhibitors
Amany Belal et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi et al.
PHARMACEUTICALS (2022)
Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
Ahmed M. Shawky et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab et al.
BIOORGANIC CHEMISTRY (2021)
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity
Fatma A. M. Mohamed et al.
BIOORGANIC CHEMISTRY (2021)
Cu(I) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action
Diogo Sequeira et al.
DALTON TRANSACTIONS (2021)
Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity
Hesham A. M. Gomaa et al.
BIOORGANIC CHEMISTRY (2020)
Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis
Ping Zhou et al.
CELLS (2019)
5-Chlorobenzofuran-2-carboxamides: From allosteric CB1 modulators to potential apoptotic antitumor agents
Bahaa G. M. Youssif et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Iso-Mukaadial Acetate from Warburgia salutaris Enhances Glucose Uptake in the L6 Rat Myoblast Cell Line
Nontokozo Z. Msomi et al.
BIOMOLECULES (2019)
Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies
Hany A. M. El-Sherief et al.
BIOORGANIC CHEMISTRY (2018)
Design, synthesis and pharmacophoric model building of new 3-alkoxymethyl/3-phenyl indole-2-carboxamides with potential antiproliferative activity
Mostafa H. Abdelrahman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2017)
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Mathew P. Martin et al.
ACS CHEMICAL BIOLOGY (2013)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS' COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013 CONSENSUS STATEMENT - EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2013)
Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides
Can Liu et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Drug Effect Prediction by Polypharmacology-Based Interaction Profiling
Zoltan Simon et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Cross-Pharmacology Analysis of G Protein-Coupled Receptors
Ferran Brianso et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Systems Pharmacology
Aislyn D. W. Boran et al.
MOUNT SINAI JOURNAL OF MEDICINE (2010)
A Multidimensional Strategy to Detect Polypharmacological Targets in the Absence of Structural and Sequence Homology
Jacob D. Durrant et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
DRUG DISCOVERY Predicting promiscuity
Andrew L. Hopkins
NATURE (2009)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Key factors in the rising cost of new drug discovery and development
M Dickson et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Functional and topological characterization of protein interaction networks
SH Yook et al.
PROTEOMICS (2004)
Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors.: Part 1:: Design, synthesis, and biological evaluation
C Jaramillo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Navigating chemical space for biology and medicine
C Lipinski et al.
NATURE (2004)
Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital
Z Hussein et al.
MEDICAL JOURNAL OF AUSTRALIA (2004)
Knockouts model the 100 best-selling drugs - Will they model the next 100?
BP Zambrowicz et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor
J Stamos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
